Co-Diagnostics's market cap is currently $18.45M. The company's EPS TTM is $-0.23; its P/E ratio is ―; Co-Diagnostics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
